FDA inspection
LEK Pharmaceuticals d.d.: FDA inspection ending Aug 30, 2019
FDA inspection 1123872 · No Action Indicated (NAI) · Lendava
Key facts
| Inspection ID | 1123872 |
|---|---|
| Firm | LEK Pharmaceuticals d.d. |
| FEI number | 3002807463 |
| Address | Trimlini 2d |
| City | Lendava |
| Country | Slovenia |
| Fiscal year | 2019 |
| Inspection end date | Aug 30, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data